Skip to main content
Premium Trial:

Request an Annual Quote

Angle Signs Distribution Deal for Parsortix Cell Sorting System in Czech Republic

NEW YORK — Angle said on Wednesday that it has signed a distribution agreement for its Parsortix PC1 cell sorting system in the Czech Republic with Promedeus.

Financial and other terms of the deal were not disclosed.

Parsortix PC1 is designed to enrich circulating tumor cells from peripheral blood. Earlier this year, it received clearance from the US Food and Drug Administration for the isolation of circulating metastatic breast cancer cells for liquid biopsy testing. At the time, UK-based Angle said it was seeking CE-IVD marking for the system.

Promedeus has "a strong track record and local knowledge which can help support the development of a new market for Parsortix," Angle Founder and CEO Andrew Newland said in a statement. "Angle expects to sign similar agreements for other key territories in due course."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.